Previous 10 | Next 10 |
2024-05-09 12:22:56 ET More on ReShape Lifesciences ReShape Lifesciences gets notice of allowance for additional U.S. patent ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan Read the full article on Seeking Alpha For further det...
Completed First Surgeries With Next-Generation Lap-Band ® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., April 01, 2024...
2024-03-28 08:56:46 ET More on ReShape Lifesciences ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earnings data for ReShape Lifesciences Financial informa...
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for...
2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for Synergistic M&A Partner Continues IRVINE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® ...
IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that bariatric surgical fellows from the University of Texas Health Center in Houston, Texas were...
2024-01-21 12:00:01 ET More on Intuitive Surgical, J&J, etc. Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuit...
(NewsDirect) ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration. Hickey told Proactive this FDA approval represents ...
IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it has engaged Maxim Group LLC, to act as the Company’s exclusive financial advisor to ...
2023-12-13 18:29:59 ET DENVER, Colo., Dec. 13, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Shattuck Labs Inc (NASDAQ: STTK), Reshape Lifesciences Inc (NASDAQ: RSLS), C4 Therapeutics Inc. (NASDAQ: CCCC), Chanson International Holding (NASDAQ: C...
News, Short Squeeze, Breakout and More Instantly...
ReShape Lifesciences Inc. Company Name:
RSLS Stock Symbol:
OTCMKTS Market:
2024-05-30 06:54:00 ET 3 Tips for Investing in AI Penny Stocks in 2024 Investing in penny stocks, particularly those tied to the burgeoning artificial intelligence sector, presents an exciting opportunity for investors looking to diversify their portfolios with potentially high-reward a...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 37.2% to $0.0494 on volume of 615,002,672 shares Innovative Eyewear Inc. (LUCY) rose 131.5% to $0.949 on volume of 566,381,896 shares Faraday Future Intelligent Electric Inc. (FFIE) fell...
A look at the top 10 most actives in the United States ReShape Lifesciences Inc. (RSLS) rose 89.7% to $0.3942 on volume of 109,324,190 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 30.3% to $0.8151 on volume of 100,649,842 shares Innovative Eyewear Inc. (LUCY) rose 61.0% to ...